News

LyondellBasell Faces Margin Challenges Amid Earnings Adjustments

LyondellBasell Faces Margin Challenges Amid Earnings Adjustments

LyondellBasell Adjusts Price Target Amid Earnings Miss

Recently, the investment firm Jefferies made a notable revision regarding LyondellBasell Industries (NYSE: LYB) stock. They have lowered their price target from $101 to $96 while maintaining a Hold rating. This decision comes in light of the company’s third-quarter earnings per share (EPS), which registered at $1.88. This figure fell short of analyst expectations by $0.62 and was also below consensus by $0.10.

Key Factors Impacting Financial Performance

An in-depth examination of LyondellBasell's financials reveals several dynamics at play affecting its performance. One key highlight is the anticipated increase in North American polyethylene (PE) volumes, which presents an opportunity for the company to enhance its market position. However, this anticipated growth might be offset by rising ethane costs, signaling potential challenges to profit margins in the near term.

Crack Spreads and Demand Concerns

The analysts also pointed out a concerning decline in crack spreads, which may hamper the company's Oxyfuels business. The existing pressure is aggravated by softer consumer and automotive demand, projected to prolong low demand for polypropylene (PP) and Advanced Polymers until at least 2025.

Strategic Initiatives and Future Developments

Despite facing these challenges, LyondellBasell's management seems committed to executing its strategic initiatives. In their recent report, the company highlighted that their portfolio transformation is progressing well. A significant milestone includes the planned shutdown of their refinery, scheduled for the first quarter of 2025. Additionally, the introduction of the MoReTec advanced plastic recycling technology is expected to begin operations by 2026, which marks a remarkable advancement in their long-term strategy.

Recent Financial Performance

In more recent news, LyondellBasell Industries N.V. announced their financial performance for the third quarter, exhibiting resilience in challenging market conditions. They reported earnings of $1.88 per share and an EBITDA of $1.2 billion, alongside $670 million generated from operations. The company is also constructing the MoReTec-1 recycling facility and plans the closure of its Houston refinery.

Segment Performance and Future Earnings

When evaluating segment performance, the Olefins and Polyolefins - Americas sector experienced a 13% increase in sequential EBITDA. Conversely, the refining segment saw a decrease, primarily due to lower gasoline crack spreads. As the company eyes future growth, their proactive approach aims to unlock at least $600 million in annual EBITDA by the end of 2024, with aspirations reaching $1 billion by the end of 2025.

Challenges in Refining Segment

On a less favorable note, the refining segment suffered a $23 million EBITDA loss, with further margin compression anticipated from diminished fuel demand in various markets and high refinery utilization rates. However, encouragingly, the profitability of the Olefins and Polyolefins - Americas segment surged by 50% year-over-year, while the Advanced Polymer Solutions segment noted a promising 20% year-to-date EBITDA increase.

Understanding Valuation and Dividend Appeal

To provide further context surrounding Jefferies’ analysis, LyondellBasell's financial metrics are worthy of attention. The company exhibits a P/E ratio of 13.14, reflecting a modest valuation, which aligns well with Jefferies' Hold rating. This metric is especially pertinent as it accommodates the aforementioned operational hurdles, including margin pressures and weak demand in specific sectors.

Attractive Dividend Offering

Another aspect that might attract investors is LyondellBasell's dividend yield of 6.19%, complemented by a dividend growth rate of 7.2% over the past year. Such a robust dividend framework provides a cushion for the stock price amid market headwinds. Moreover, it is worth noting that LyondellBasell has consistently maintained its dividend payments for an impressive 13 consecutive years, demonstrating its commitment to rewarding shareholders throughout various industry cycles.

Frequently Asked Questions

Why did Jefferies lower LyondellBasell's price target?

Jefferies lowered LyondellBasell's price target due to a disappointing earnings report and concerns regarding margin pressures.

How did LyondellBasell perform in the third quarter?

LyondellBasell reported an EPS of $1.88 and an EBITDA of $1.2 billion, showing resilience in tough market conditions.

What are the expected challenges for LyondellBasell?

Challenges include rising ethane costs, declining crack spreads, and weak consumer demand impacting polypropylene and advanced polymers.

What strategic initiatives is LyondellBasell pursuing?

LyondellBasell is focusing on portfolio transformation, shutdown of their refinery, and advancing their MoReTec recycling technology.

Why is dividend growth important for investors?

Dividend growth indicates a company's financial health and commitment to shareholder returns, providing stability amid market fluctuations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 0

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 113

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Don Silvestri: NFL Vet's Service Legacy Continues

Updated Category News Views 64

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Continue Reading
CORE Embraces Tech to Boost Organ Donation Efforts

Updated Category News Views 73

Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...

Continue Reading
MillerKnoll's 3D Push: Legacy Meets Innovation

Updated Category News Views 42

Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...

Continue Reading
Dotwork's AI Leap: Acquires Arcario to Revolutionize Strategy

Updated Category News Views 84

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Continue Reading
Boeing's Third Quarter 2026: Progress Amid Losses

Updated Category News Views 97

Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...

Continue Reading

Top 5 Most Recently Viewed Articles

SMCP Reports Strong Sales Growth Backed by Strategic Plans

Updated Category News Views 229

Strong Sales Growth in Q3 for SMCP The latest sales report for SMCP has highlighted a solid growth trajectory in the third quarter. The performance is attributed to robust activities in the America and EMEA regions, showcasing the effectiveness of the company's strategic initiatives. Sales Overview and Highlights In the first nine months of 2025, SMCP achieved impressive...

Continue Reading
InflaRx Set to Showcase Innovations at Upcoming Investor Events

Updated Category News Views 187

InflaRx to Participate in Major Investor Conferences In a noteworthy announcement, InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company specializing in anti-inflammatory therapeutics, is gearing up for participation in two significant investor conferences in September. This engagement comes as the company continues to push boundaries in treating inflammatory...

Continue Reading
Rapid7's Participation at Major Industry Conference

Updated Category News Views 141

Rapid7 to Attend Prominent Conference Rapid7, Inc. (NASDAQ:RPD), a frontrunner in threat detection and exposure management, has recently announced its participation in a significant event: the Raymond James TMT and Consumer Conference. This notable conference will take place in New York, providing a platform where industry leaders gather to discuss innovations and...

Continue Reading
Theriva Biologics Expands Opportunities with New Offering

Updated Category News Views 136

Theriva Biologics Expands Opportunities with New Offering Theriva Biologics (NYSE American: TOVX), a clinical-stage company focused on developing innovative cancer therapeutics, has recently completed a significant public offering aimed at raising $7.5 million. This initiative is not only a financial step for Theriva but also a strategic move to enhance its research...

Continue Reading
Costco Welcomes Gina Raimondo to its Board of Directors

Updated Category News Views 211

Costco's New Board Nominee Costco Wholesale Corporation (NASDAQ: COST) has announced the nomination of Gina Raimondo to its Board of Directors. Raimondo, who has an impressive track record, served as the 40th Secretary of Commerce and held the position of Governor of Rhode Island. Her political career began in 2010 when she was elected as the Treasurer of Rhode Island....

Continue Reading